Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2023 May 1;32(5):659–665. doi: 10.1158/1055-9965.EPI-22-1038

Figure 1:

Figure 1:

Prevalence over time for all races, assuming equal de novo and recurrent survival. Solid black line represents estimated number of new metastatic prostate cancer (MPC) cases; dashed blue line represents observed number of prostate cancer (PC) deaths; dotted red line indicates projections after 2018.